Publications by authors named "M Baltzan"
Objectives: Obstructive sleep apnea (OSA) is a common chronic condition that is often undiagnosed or diagnosed after many years of symptoms and has an impact on quality of life and several health factors. We estimated the Canadian national prevalence of OSA using a validated questionnaire and physical measurements in participants in the Canadian Longitudinal Study on Aging (CLSA).
Methods: The method used individual risk estimation based upon the validated STOP-BANG scale developed for OSA.
Background: Obstructive sleep apnea (OSA) is associated with worse outcomes in stroke, Alzheimer's disease (AD) and Parkinson's disease (PD), but diagnosis is challenging in these groups. We aimed to compare the prevalence of high risk of OSA based on commonly used questionnaires and self-reported OSA diagnosis: 1. within groups with stroke, AD, PD and the general population (GP); 2.
View Article and Find Full Text PDFA Pilot Randomized Trial of Combined Cognitive-Behavioral Therapy and Exercise Training Versus Exercise Training Alone for the Management of Chronic Insomnia in Obstructive Sleep Apnea.
J Sport Exerc Psychol
June 2024
Insomnia treatment among individuals with comorbid insomnia and obstructive sleep apnea is suboptimal. In a pilot randomized controlled trial, 19 individuals with comorbid insomnia and obstructive sleep apnea were allocated to one of two arms: EX + EX, consisting of two 8-week phases of exercise training (EX), or RE + CBTiEX, encompassing 8 weeks of relaxation training (RE) followed by 8 weeks of combined cognitive-behavioral therapy and exercise (CBTiEX). Outcomes included Insomnia Severity Index (ISI), polysomnography, and cardiorespiratory fitness measures.
View Article and Find Full Text PDFArticle Synopsis
- A previous study found that 80% of older family medicine patients tested for obstructive sleep apnea (OSA) were diagnosed with the condition, prompting further research on treatment uptake and symptom characteristics.
- In the current study, 101 women and 75 men over 45 were tested for OSA, with 93% diagnosed and 53 starting treatment, primarily through PAP therapy.
- After 3 years, only 24 remained consistent with their treatment, showing improvements in insomnia and daytime symptoms, suggesting that while increased testing identified more cases, treatment adoption and adherence were low, indicating a need for more targeted support strategies.